These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9218069)

  • 1. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
    Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
    Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
    Carlsson R; Dent J; Watts R; Riley S; Sheikh R; Hatlebakk J; Haug K; de Groot G; van Oudvorst A; Dalväg A; Junghard O; Wiklund I
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):119-24. PubMed ID: 9581986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.
    Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ
    Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L
    Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole.
    Hatlebakk JG; Berstad A
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1093-9. PubMed ID: 9663835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole for maintenance of remission of erosive oesophagitis.
    Freston JW; Jackson RL; Huang B; Ballard ED
    Drugs; 2002; 62(8):1173-84. PubMed ID: 12010078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
    Bloom BS; Hillman AL; LaMont B; Liss C; Schwartz JS; Stever GJ
    Pharmacoeconomics; 1995 Oct; 8(4):343-9. PubMed ID: 10155675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis.
    Sharma VK; Leontiadis GI; Howden CW
    Aliment Pharmacol Ther; 2001 Feb; 15(2):227-31. PubMed ID: 11148442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.
    Bardhan KD; Cherian P; Vaishnavi A; Jones RB; Thompson M; Morris P; Brooks A; D'Silva J; Gillon KR; Wason C; Patterson J; Polak J; Bishop A
    Gut; 1998 Oct; 43(4):458-64. PubMed ID: 9824569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
    Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
    Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
    Hassall E; Shepherd R; Koletzko S; Radke M; Henderson C; Lundborg P
    Aliment Pharmacol Ther; 2012 Feb; 35(3):368-79. PubMed ID: 22176465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis.
    Bate CM; Green JR; Axon AT; Tildesley G; Murrays FE; Owen SM; Emmas C; Taylor MD
    Aliment Pharmacol Ther; 1998 Jan; 12(1):41-7. PubMed ID: 9692699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
    Barradell LB; McTavish D
    Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.